Agreement expands Cardio Diagnostics' global footprint and supports improved detection and management of coronary heart disease in India.

Once integration is completed, the partners plan to accelerate commercial rollout across India, anticipated in 2026.

Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs partner to bring PrecisionCHD test to India, aiming to address high heart ...

Cardio Diagnostics Holdings will partner with a longtime distribution leader in India and an Indian network of nearly 300 ...

The launch comes at a time when Dr Lal PathLabs continues to rely on volume-led growth, having not taken a price hike in the ...

BENGALURU, Aug 7 (Reuters) - Dr. Lal PathLabs (DLPA.NS), opens new tab reported first-quarter profit above expectations on Wednesday on strong demand for its medical tests in smaller cities and towns ...

BENGALURU (Reuters) - Dr. Lal PathLabs, India's biggest diagnostics firm by revenue, posted a higher profit for the third straight quarter on Thursday, due to more diagnostics and tests in the monsoon ...

Dr Lal PathLabs is focusing on innovation, including new wellness packages and high-end, super-speciality tests, with a focus ...

Dr Lal PathLabs, one of the largest lab testing companies in India, left a huge cache of patient data on a public server for months, TechCrunch has learned. The lab testing giant, headquartered in New ...